InspireMD (NSPR) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on InspireMD (NSPR) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.13 of bullish evidence against -0.39 bearish.

InspireMD last closed at $0.58, -6.45% on the session.

Against the IVW growth benchmark the position is -7.37% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

InspireMD has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks InspireMD in the 10th percentile on return on equity, where 100 is best.

InspireMD is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $28.94M.

StockMap tracks InspireMD as the 117th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite InspireMD ranks 107th of 133 in the group, against a group median of -0.21.